The Evolution of the OTC - PowerPoint PPT Presentation

About This Presentation
Title:

The Evolution of the OTC

Description:

The Evolution of the OTC A comprehensive approach to technology commercialization The Texas A&M University System Corporate Relations Benchmarks University of ... – PowerPoint PPT presentation

Number of Views:229
Avg rating:3.0/5.0
Slides: 57
Provided by: Christin632
Learn more at: https://utenportugal.org
Category:

less

Transcript and Presenter's Notes

Title: The Evolution of the OTC


1
The Evolution of the OTC
  • A comprehensive approach to technology
    commercialization

The Texas AM University System
2
Workshop Outcome Goals
  • Develop mission oriented criteria for each
    institution technology commercialization program
  • Define spin-off/new company creation models that
    work in the Portuguese context
  • Develop an internal venture opportunity plan for
    a university technology from your institution

3
Workshop Methodology
  • Form teams around universities that have a
    technology that may be the basis of a spin-off
    company.
  • If you havent brought a technology, join with
    another team
  • Develop strategic thinking and materials for your
    university

4
Work Groups
  • University groups
  • If you did not bring a technology, join with a
    university that did
  • Technology briefing
  • What
  • Why
  • Connection
  • Next steps

5
The Nine Points A Common Understanding
  • Universities should reserve the right to practice
    licensed inventions and to allow other non-profit
    and governmental organizations to do so
  • Exclusive licenses should be structured in a
    manner that encourages technology development and
    use

6
The Nine Points
  • Strive to minimize the licensing of future
    improvements
  • Universities should anticipate and help to manage
    technology transfer related conflicts of interest
  • Ensure broad access to research tools

7
The Nine Points
  • Enforcement action should be carefully considered
  • Be mindful of export regulations
  • Be mindful of the implications of working with
    patent aggregators

8
The Nine Points
  • Consider including provisions that address unmet
    needs, such as those of neglected patient
    populations or geographic areas, giving
    particular attention to improved therapeutics,
    diagnostics and agricultural technologies for the
    developing world

9
A Common Understanding
  • The nine points help to guide university
    licensing
  • They are common themes across universities
  • They provide the guardrails for licensing
  • They help to guide the activities of the
    technology transfer office
  • Is a successful commercialization office all
    about the licensing function working well?

10
Why We Do What We Do
  • Translate discoveries into products
  • Connects to the service mission of the university
  • Payback to the taxpayers that support the
    university in better products
  • May generate a cash return
  • Generate economic development
  • Protect our commercial partners investments with
    intellectual property
  • Enable the commercial partners to invest in the
    product
  • Sometimes is required to commercialize

11
Primary Concept
  • The main motivation for a university to transfer
    technology is an extension of its basic mission
    to teach, to generate and share new knowledge,
    and to be of service to society. And sometimes
    technology transfer generates significant income
    for the company partner and the university. By
    maintaining the core values of the university
    while working with the private and public sectors
    to enable development of products, those of us in
    the technology transfer profession help change
    the world.
  • Agree? Anything to add?

12
Other Impact Points
  • What is in the mission statement of every
    university
  • Research
  • Education
  • Public service/public good
  • Can (should) technology commercialization impact
    all 3 parts of the mission statement?
  • Is this how you think about your mission?

13
What Is Your Mission?
  • How does your technology commercialization
    mission support the university mission?
  • How do you currently measure impact?
  • How should you measure impact if you want to
    impact the university mission?

14
Define Your Mission and Measurements
  • How do you want the university to define your
    mission?
  • How do you want to be measured?

15
Texas AM System Overview
  • OTC Facts
  • Evolving Demands
  • The Three Paths to Commercialization
  • Direct Licensing
  • RD Alliances
  • Start-Up Formation
  • Partnership

16
The Office of Technology Commercialization
  • Since its founding, the OTC has
  • Processed more than 2,400 inventions created by
    AM System faculty and staff
  • Filed more than 2,700 patent applications
  • Completed more than 1,700 License Agreements and
    Material Transfer Agreements
  • Generated revenues exceeding 60 million related
    to intellectual property rights

17
The Office of Technology Commercialization
  • Revenues have gone to support
  • More than 20 million in sponsored research
  • Retention of important faculty
  • Support for more than 800 faculty and staff
    inventors
  • Sharing arrangements with co-developers like USDA
    and other universities

18
The Office of Technology Commercialization
  • The OTC
  • Became the youngest technology transfer office in
    the top 25 in North America in revenues
  • Is in the top ten in the number of license
    agreements producing income
  • Does two-thirds of its license agreements with
    small businesses
  • Files a patent every other day
  • Completes a license agreement once a week

19
Impact of License Revenues at Texas AM System
  • 10 million in one year.
  • Successful?
  • Where does that money go?
  • 1 million for patent expenses
  • 2.25 million to run OTC
  • 3.375 million directly to inventors
  • 3.375 million spread across System Members with
    a combined budget of 3 billion
  • Is that impactful to Texas AM System?

20
In 2005 OTC Defined Commercialization Broadly
  • Licensing alone has minimal impact on the mission
    of the university
  • Education
  • Research
  • Public Service/Public good
  • University commercialization must be broader than
    licensing
  • Industry-university partnerships are key to
    commercialization success

21
Office of Technology Commercialization
  • OTC is a matchmaker between System members and
    commercial partners
  • Single point of contact for partners
  • OTC works across silos
  • OTC defines commercialization broadly
  • Licensing
  • New venture creation
  • Increased research flow
  • Assist with new research infrastructure

22
Evolving Demands
  • OTCs strength has been direct licensing
  • This is one of three basic activities that any
    technology commercialization office must be
    proficient in
  • As Texas AM becomes more sophisticated, the OTC
    is challenged to improve in other areas
  • The future of the OTC lies in improving our
    abilities in the other two sectors of activity

23
Scope of OTC Services
  • Direct Licensing
  • Research and Development Alliances
  • Industry
  • State/Federal
  • Start-Up Formation

24
Improving Direct Licensing
  • Triage and Assessment
  • Preliminary Reports
  • Interview Reports
  • Communication of Commercialization Plan
  • Intellectual Property Strategy
  • Marketing Strategy
  • Disciplined selection of opportunities
  • Follow-through
  • Transparency

25
Technology Evaluation Matrix
Low Licensing Risk High Licensing Risk
High Reward High Value-Added (Prioritize) Cost Drivers (Make a few smart picks where risk can be reduced close the rest.)
Low Reward Low Value-Added (Maintain low risk, increase reward if possible) Non Value-Added (Waive/Release to Inventors)
26
Market Research Reports Help to Manage Risk
Low Licensing Risk High Licensing Risk
High Reward Meet Technical Milestones Cost Drivers
Low Reward Trade Value for Risk Reduction Waive/Release
27
Industrial RD Alliances
  • Finding corporate partners to bring technology
    development forward
  • In the past, reliance on faculty to initiate
    these
  • Currently, members of licensing staff dedicate
    time to pursuit of industry alliances

28
(No Transcript)
29
Scope of System Capabilities
  • 11 Universities and the Health Science Center
  • Campuses in Texas and the Persian Gulf state of
    Qatar
  • 7 state agencies
  • 27,000 faculty and staff
  • Performed 637 million in externally funded
    research
  • Physical and Program presence in all of the
    states 254 counties
  • In 2008 the AM System
  • educated 106,000 students in degree programs
  • 22,888 degrees awarded
  • More than 1 in 5 students enrolled in a
    public university in Texas is attending an AM
    System institution
  • Agencies trained hundreds of thousands more
    students through practical extension programs

30
Single Point of Contact
  • The need is clear, but how?
  • The System was the only organization which
    spanned the Members
  • OTCs business focus made it a natural fit for
    the job
  • Referred clients to appropriate
    Members/laboratories
  • Worked across silos
  • Recognized synergies between industrial clients
    and multiple Members
  • Initially organized under Business Development in
    OTC

31
OTC and Business Development(Philosophy of
working with the Marketplace)
  • Understanding commercial needs and demands can
    uncover collaboration opportunities and potential
    funding
  • Offer need-driven research opportunities to the
    researchers
  • Collaboration opportunities are an outcome of
    researchers gaining an understanding of
    commercialization
  • Long-term commercial partnerships lead to
    research funding opportunities

32
Start Small - Build Upon Success
  • Bio-energy efforts were greatly assisted by OTC
  • Worked closely with AgriLife Research and
    AgriLife researchers
  • Led to millions of dollars in sponsored research
  • Enabled AgriLife to pay for dedicated Corporate
    Relations staff
  • Has led to many more deals in AgriLife with large
    industrial partners

33
Model is Evolving
  • Moving towards a distributed Corporate Relations
    model
  • Multiple offices/people in each of the major
    Member organizations
  • Created a new Associate Vice-Chancellor for
    Economic Development
  • Coordinates efforts and helps to create bridges
    between organizations

34
Corporate Relations Benchmarks
  • University of Wisconsin, Madison
  • Office of Corporate Relations, Wisconsin Alumni
    Research Foundation, Research Park, WiSys
  • Purdue University
  • Office of Engagement, Office of Technology
    Commercialization, Research Park, PURE Database
  • University of Michigan
  • Academic and Corporate Relations Center

35
Operational Model
36
State and Federal RD Alliances
  • Finding state and federal sponsors to bring
    technology development forward
  • These alliances may include industry partners as
    well
  • In the past, reliance on faculty to initiate
    these
  • Currently, senior staff dedicate time to pursuit
    of these alliances

37
State and Federal RD Alliances
  • Guy Diedrich
  • Vice Chancellor for Federal Relations and
    Commercialization
  • Mark M. Ellison 
  • Associate Vice Chancellor for Economic
    Development
  • Dennis Beal 
  • Director, Industry Alliances

38
Get Involved Early
  • Build a team of Trusted Technology Advisors for
    our two customer bases
  • University researchers
  • industry/investment partners
  • Long-term commercial partnerships can lead to
    research opportunities
  • Collaboration opportunities are an outcome of
    researchers gaining an understanding of
    commercialization

39
Start-Up Formation
  • Creating companies
  • to allow us to move disruptive technologies
    forward
  • to allow us to get a greater return on new
    technologies
  • In the past, reliance on entrepreneurial faculty
    to initiate these
  • Currently, have a dedicated team that focuses on
    formation of start-ups

40
OTC and Start-up Creation(Establishing New
Business Entities)
  • Identify opportunities with start-up potential
    for equity investment
  • Assist with market research, business planning
    and partnering (Commercialization Services)
  • Partnering with early stage capital funds,
    investors, and strategic partners
  • Focus on the relationship and be demand driven
  • Provide incubation possibilities at Texas AM or
    with partners
  • Be born big with international presence from the
    beginning

41
The Pursuit of Regional Knowledge-based
CompetitivenessVISION
  • Build global companies from start-up by
    leveraging a network of networks built by
    technology commercialisation partners around the
    world
  • Technology networks
  • VC / High Net Worth Individual networks
  • Industry networks
  • Management networks

42
An Example of The Pursuit of Regional
Knowledge-based Competitiveness
  • Memorandum of Understanding (MOU) between
    Wallonia Export and Investment on one side and
    Texas AM System on the other.
  • Wallonia is a partner of Texas AM in the
    European Union for the commercialisation of their
    technologies.
  • AWEX is the contact point in Belgium for the
    realisation of the MOU at all Universities,
    Incubators, and Competitiveness Clusters .
  • The MOU is based on reciprocity.

43
Creating a Joint Enterprise
  • Co-Identify
  • Co-Protect
  • Co-Invest
  • Co-Locate
  • Co-Market

44
The Model
  • Start with two locations

Wallonia
Texas
Co-Identify
Co-Protect
Co-Invest
Co-Locate
Co-Market
45
The Model
  • Spread the wealth

EU
US
China
Middle East
Latin Am
Co-Identify
Co-Protect
Co-Invest
Co-Locate
Co-Market
46
Results of Defining Commercialization Broadly
  • 170 million in new revenue since 2006
  • State industry university research institutes
  • State - industry university partnerships to
    attract star researchers
  • Industry university multi-year research
    programs
  • Direct impact on the mission
  • Education, research, public good

47
Keys to Success
  • Top administrator support for commercialization
  • Key staff are from industry and speak the
    language of business
  • Commercialization becomes part of the project
    design
  • Industry partners know their ultimate goal is
    important to the university as well
  • Thinking beyond licensing to other possible
    business support
  • Development funding
  • New venture creation

48
Get Involved Early
  • Build a team of Trusted Technology Advisors for
    our two customer bases
  • University researchers
  • industry/investment partners
  • Long-term commercial partnerships can lead to
    research opportunities
  • Collaboration opportunities are an outcome of
    researchers gaining an understanding of
    commercialization

49
Start-Up Formation
  • Creating companies
  • to allow us to move disruptive technologies
    forward
  • to allow us to get a greater return on new
    technologies
  • In the past, reliance on entrepreneurial faculty
    to initiate these
  • Currently, have a dedicated team that focuses on
    formation of start-ups

50
TAMUS Approach
  • Inventor led spin-out vs. university led spin-out
  • Small equity stake vs large equity stake
  • No investment vs cash investment
  • No university business involvement vs university
    board seats
  • Part time professor CEO vs full time CEO
  • Small university upside vs large university
    upside

51
What Are Spin-Out Opportunities?
  • Goldilocks technologies
  • Not developed enough to attract licensees
  • Developed enough to attract angels
  • Next steps usually involve further research at
    the university
  • Value add step is relatively inexpensive
  • Large market fundable, exit strategy

52
Example Spin-Out
  • MacuClear
  • MacuCLEAR completed a Series A private placement
    totaling 1.5M to complete preclinical studies
    and attain the IND for activation of human
    clinical trials. In March 2009, MacuCLEAR also
    received follow-on investment of 1.7M from the
    Texas Emerging Technology Fund to complete Phase
    Ib human trials.

53
Example Spin-Out
  • Salient
  • Salient launched a CASAD Phase Ib human clinical
    trial at MD Anderson Cancer Center in Feb 2009,
    and trial results are expected in Q1 2010.
    Salient has raised 1.5M in convertible debt to
    support Phase Ib clinical trials and to fund
    ongoing testing at Texas AM University
    identifying additional follow-on applications for
    CASAD. Salient has also been identified as a
    finalist to receive a 2.1M award from the Texas
    Emerging Technology Fund to support Phase II/III
    trials and follow-on applications.

54
Spinouts
  • Spinout companies are a tool, not the only tool.
  • Example scenarios
  • Belsim
  • Global BioDiagnostic
  • Lisam

55
Our goal is not only to discoverknowledge, but
to apply it, Chairman Bill Jones Board of
Regents
56
What Tools Can Be Applied In Your Model?
  • Portfolio management?
  • Involvement in developing industrial
    relationships/research programs?
  • Involvement in strategic research initiatives?
  • Economic development mission?
  • University led startups?
  • International startup partnerships?
Write a Comment
User Comments (0)
About PowerShow.com